68 / 72
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016
122
AFRICA
disease.
Cardiovasc Res
2014;
4
: 554–560.
3.
Moodley J. Maternal deaths associated with eclampsia in South Africa:
Lessons to learn from the confidential enquiries into maternal deaths,
2005–2007 Causes of hypertensive maternal deaths in South Africa.
Sth
Afr Med J
2010;
100
(11): 718–719.
4.
Rosengren A, Hawken S, Ounpuu S,
et al.
Association of psychosocial
risk factors with risk of acute myocardial infarction in 11119 cases and
13648 controls from 52 countries (the INTERHEART study): case-
control study.
Lancet
2004;
364
(9438): 953–962.
5.
Honikman S, van Heyningen T, Field S, Baron E, Tomlinson M.
Stepped care for maternal mental health: a case study of the perinatal
mental health project in South Africa.
PLoS Med
2012;
9
(5): 1–6.
6.
Hartley M, Tomlinson M, Greco E,
et al.
Depressed mood in pregnancy:
Prevalence and correlates in two Cape Town peri-urban settlements.
Reprod Health
2011;
8
(1): 9.
7.
Bunevicius R, Kusminskas L, Bunevicius A, Nadisauskiene RJ,
Jureniene K, Pop VJM. Psychosocial risk factors for depression during
pregnancy.
Acta Obstet Gynecol
2009;
88
: 599–605.
8.
Joynt KE, Whellan DJ, Connor CMO. Depression and cardiovascular
disease: Mechanisms of interaction.
Biol Psychiat
2003;
54
: 248–261.
9.
Clapp C, Thebault S, Martínez de la Escalera G. Hormones and post-
partum cardiomyopathy.
Trends Endocrinol Metab
2007;
18
: 329–330.
10. Billingham R, Brent L, Medawar PB. “Actively acquired tolerance” of
foreign cells.
Nature
1953;
172
: 603–606.
11. Romero R, Gomez R, Grezzi F, Yoon B, Mazor M, Eddwin S. A foetal
systemic inflammatory response is followed by the spontaneous onset
of preterm parturition.
J Obstet Gynaecol Gynecol
1998;
179
: 186–93.
12. Leinwand LA. Molecular events underlying pregnancy-induced cardio-
myopathy.
Cell
2007;
1
: 437–438.
13. Sies H.
Oxidative stress II. Oxidants and antioxidants
. London: Academic
Press, 1991: 10–20.
14. Biondi C, Pavan B, Lunghi L, Fiorini S, Vesce F. The role and modula-
tion of the oxidative balance in pregnancy.
Curr Pharm Des
2005;
2
:
2075–2089.
15. Casanueva E, Viteri F. Iron and oxidative stress in pregnancy.
World
Health
2003;
133
: 1700–1708.
16. Davies CJ. Why is the fetal allograft not rejected?
J Anim Sci
2007;
85
(13
Suppl): E32–35. doi:10.2527/jas.2006-492.
17. Murphy K.
Janeway’s Immunobiology
, 8th edn. New York: Garland
Science, 2011, ch 4: 20–40.
18. Ober C. HLA and pregnancy: the paradox of the fetal allograft.
Am J
Hum Genet
1998;
62
: 1–5.
19. Sunami R, Komuro M, Tagaya H, Hirata S. Migration of microchi-
meric fetal cells into maternal circulation before placenta formation.
Chimerism
2010;
1
(2): 66–68.
20. Yeh CC, Chao CK, Huang SJ. Innate immunity, decidual cells, and
preeclampsia.
Reprod Sci
2013;
4
: 339–343.
21. Al-Othman S, Omu AE, Diejomaoh FME, Al-Yatama M, Al-Qattan
F. Differential levels of interleukin 6 in maternal and cord sera and
placenta in women with pre-Eclampsia.
Obstet Investig
2001;
52
: 60–62.
22. Mosca L, Benjamin EJ, Berra K,
et al
. Effectiveness-based guidelines for
the prevention of cardiovascular disease in women – 2011 update.
J Am
Coll Cardiol
2011;
57
(12): 1404–1423.
23. Siu SC, Sermer M, Colman JM,
et al
. Clinical investigation and reports
prospective multicenter study of pregnancy outcomes in women with
heart disease.
Circulation
2001;
104
: 515–521.
24. Arbour MW, Corwin EJ, Salsberry PJ, Atkins M. Racial differences in
the health of childbearing-aged women.
Medicine (Baltimore)
2012;
37
(4): 263–268.
25. Villar J, Say L, Shennan A,
et al
. Methodological and technical issues
related to the diagnosis, screening, prevention, and treatment of
pre-eclampsia and eclampsia.
Int J Gynaecol Obstet
2004;
85
: 28–41.
doi:10.1016/j.ijgo.2004.03.009.
26. Villar J, Purwar M, Merialdi M,
et al
. World Health Organisation
multicentre randomised trial of supplementation with vitamins C and
E among pregnant women at high risk for pre-eclampsia in populations
of low nutritional status from developing countries.
J Obstet Gynaecol
(Lahore)
2009;
116
: 780–788.
27. Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peri-
partum cardiomyopathy.
Nat Rev Cardiol
2014;
11
(6): 364–707.
28. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy:
Recent insights in its pathophysiology.
Trends Cardiovasc Med
2008;
18
(5): 174–179.
29. Sliwa K, Förster O, Libhaber E,
et al
. Peripartum cardiomyopathy:
inflammatory markers as predictors of outcome in 100 prospectively
studied patients.
Eur Heart J
2006;
27
: 441–446.
30. Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardio-
vascular disease: the problems and implications of overlapping affective
dispositions.
Psychol Bull
2005;
131
(2): 260–300.
31. The global burden of disease 2004 update. Geneva: WHO Press, 2008.
32. Anda R, Williamson D, Jones D,
et al
. Depressed affect, hopeless-
ness, and the risk of ischemic heart disease in a cohort of U.S. Adults.
Epidemeology
1993;
4
(4): 285–294.
33. Vaccarino V, Johnson BD, Sheps DS,
et al
. Depression, inflammation,
and incident cardiovascular disease in women with suspected coronary
ischemia: the National Heart, Lung, and Blood Institute-sponsored
WISE study.
J Am Coll Cardiol
2007;
50
(21): 2044–2050.
34. Muzik M, Borovska S. Perinatal depression: implications for child
mental health.
Ment Health Fam Med
2010;
4
: 239–248.
35. O’Hara MWO. Postpartum depression: What we know.
J Clin Psychol
2009;
65
(12): 1258–1270.
36. Lumley J, Austin M. What interventions may reduce postpartum depres-
sion.
Curr Opin Obstet Gynecol
2001;
13
: 605–611.
37. Adewuya AO. The maternity blues in Western Nigerian women:
Prevalence and risk factors.
Psychiat Interpers Biol Process
2005;
193
:
1522–1525.
38. Verkerk GJM, Pop VJM, van Son MJM, van Heck GL. Prediction of
depression in the postpartum period: a longitudinal follow-up study in
high-risk and low-risk women.
J Affect Disord
2003;
77
: 159–166.
39. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression
and anxiety in early pregnancy and risk for preeclampsia.
Obstet
Gynecol
2000;
95
(4): 487–490.
40. Rumsfeld JS, Havranek E, Masoudi FA,
et al.
Depressive symptoms
are the strongest predictors of short-term declines in health status in
patients with heart failure.
J Am Coll Cardiol
2003;
42
: 1811–1817.